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Background: There is a need to explore the dimensional and categorical phenotypes of criteria of opioid
use disorder among frequent nonmedical users of prescription opioids (NMUPO) users.
Methods: We used pooled data of 2011e2012 National Survey on Drug Use and Health to examine
reliability and phenotypic variability in the diagnosis of OUD secondary to NMUPO in a nationally-
representative sample of 18þ years-old frequent past-year NMUPO users (120þ days, n ¼ 806).
Through exploratory factor analysis (EFA) and latent class analysis (LCA), we examined 10 past-year OUD
criteria. We examined associations between the latent classes and sociodemographic/psychiatric/
NMUPO correlates.
Results: OUD criteria were unidimensional, and a three-class model was the overall best fitting solution
for characterizing individuals into phenotypes along this unidimensional continuum: a “non-symp-
tomatic class” (40.7%), “Tolerance-Time spent class” (29.0%) with high probability of endorsing Tolerance/
Time Spent criteria, and a “High-moderate symptomatic class” (30.1%). The last class was significantly
associated with being male, having insurance and obtaining prescription opioids (PO) nonmedically via
“doctor shopping” as compared to the non-symptomatic class. “Tolerance-Time spent class” was
significantly associated with being younger (18e25 years) and obtaining PO nonmedically from family/
friends as compared to the non-symptomatic class.
Conclusion: This study revealed the different characteristics and routes of access to PO of different classes
of frequent NMUPO users. It is possible that these groups may respond to different interventions,
however such conclusions would require a clinical study.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
In 2014, there was a higher number of opioid overdoses deaths
than in any year on record (CDC, 2015). Overdoses from prescrip-
tion opioid pain relievers play the main role in this increase in
opioid overdose deaths e at least half of these deaths involve apidemiology, Department of
lumbia University, 722 West
. Martins).prescription opioid (CDC, 2015). Since 1999, U.S. prescription opi-
oids sold nearly quadrupled (CDC, 2011). Despite the evident
importance of opioid misuse in public health, few studies have
examined the unidimensional diagnostic structure of Opioid Use
Disorders (OUD) through factor analysis (FA) and item response
theory (IRT) (Boscarino et al., 2011; Saha et al., 2012). Even fewer
studies have focused on the diagnostic structure as it applies spe-
cifically to non-medical use of prescription opioids (NMUPO) (Wu
et al., 2009, 2011). FA is a technique that allows reduction of a
large number of interrelated variables, such as the DSM criteria
(APA, 2013) for OUD, to a smaller number of hidden dimensions (or
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according to DSM-5 (APA, 2013). In addition, IRT provides mathe-
matical models for the dimensional structure, proposing forms of
representing how individuals fulfill each DSM-5 OUD criteria.
Considering that OUD can be a clinically heterogeneous syn-
drome (Kendler et al., 2013), studies have also used latent class
analysis (LCA) to better understand phenotypic differences of DSM-
IV OUD criteria among NMUPO (Ghandour et al., 2008; Wu et al.,
2011). LCA generates categorical phenotypes (individuals sub-
groups, subtypes or clusters) based on the response pattern likeli-
hood and is in line with the identification of categorical diagnosis
within the unidimensional OUD structure. In the case of DSM-IV
criteria for Opioid Dependence for NMUPO, there is a certain de-
gree of uncertainty on which should be the best LCA model (2 or 4
classes) (Wu et al., 2011; Ghandour et al., 2008). A reliable model
should be repeated in different samples of the general population
of the same country. Therefore, it is important to continue inves-
tigating this matter in more recent samples. This is even more
important nowadays, considering the new edition of DSM (DSM-5),
which created a new categorization of symptoms that one needs to
report to be classified as having an OUD (APA, 2013).
To date, no study has yet examined phenotypic variation in OUD
criteria among frequent NMUPO users. Frequent NMUPO users are
of interest because they reflect more accurately the experiences of
individuals at high risk of becoming dependent and those already
dependent. These frequent users also have a more active role in
obtaining pharmaceutical opioids compared to infrequent users
(Daniulaityte et al., 2014). In addition, between 2002 and 2010, the
rate of NMUPO increased significantly in U.S., paralleling with in-
creases in treatment admissions, overdose deaths, and other
negative effects associated with NUMPO in the same period
(Paulozzi et al., 2011; Jones, 2012). Examining the categorical
phenotypes of OUD among frequent NMUPO users can provide
insight into potential subtypes of the most problematic NMUPO
users.
Knowing about the potential OUD subtypes (classes) among
NMUPO, we gain the ability to identify groups of users that: have
different socio-demographic correlates; seek for PO in different
ways (i.e., doctor shopping); have different evolution over time and
different clinical and psychiatric comorbidities; who respond and
search differently to treatment available; among other character-
istics of interest. For instance, knowing which are the subgroups
that engage in doctor shopping is extremely useful information for
practitioners and researchers. Doctor shopping is when someone
consults different doctors obtaining overlapping prescriptions
(Nordmann et al., 2013), and is considered one of themainmeans of
diversion for prescription medications in the United States
(Lineberry and Bostwick, 2004; Pradel et al., 2004).
Through confirmatory FA and IRT, we confirmed and explored
the unidimensional model of OUD for a general population sample
of frequent NMUPO users in the US. To do this, we generated a
proxy of DSM-5 criteria. In addition, we use LCA to explore cate-
gorical phenotypes within the best dimensional model using 10
criteria from DSM-5 OUD. We further examine the sociodemo-
graphic, psychiatric and NMUPO sources (i.e., doctor-shopping,
family/friends) correlates of membership in each latent class, co-
morbidity of each latent class with other types of substance use
disorders, and treatment-seeking behavior.
2. Material and methods
2.1. Sample
In 2011e2012, the National Survey of Drug Use and Health
(NSDUH) collected data from 138,418 respondents [n(2011) ¼ 70,109; n (2012) ¼ 68,309] aged 12 or older and was
designed to obtain representative samples from the 50 States and
the District of Columbia (SAMHSA, 2012, 2013). Two consecutive
NSDUH years were combined in order to increase the sample size of
frequent NMUPO users (please see more details on Supplementary
File 6).
2.2. Measures
The NSDUH questionnaire has reliability for substance use in the
past-year and lifetime ranging from 0.72 to 0.93 and 0.71 to 0.95,
respectively (Jordan et al., 2008; National Household Survey on
Drug Abuse, 2010a,b, 2012, 2013). For past-year and lifetime
NMUPO, kappa coefficient is respectively 0.73 and 0.78. As with all
self-report surveys, the validity of responses to questions on sub-
stance use and diagnostic symptoms of SUD may be biased. Jordan
et al. (2008) have conducted a study to investigate the clinical
validity of SUD symptoms in the NSDUH using the Structured
Clinical Interview for DSM-IV (SCID-IV) for adults and the Pitts-
burgh Adolescent Alcohol Research Center’s Structured Clinical
Interview (PAARC-SCID) for adolescents. Their study showed the
level of agreement between the NSDUH and the SCID/PAARC-SCID
interviews to be fair to moderate overall. There was somewhat
better agreement for dependence than for abuse and for adults than
for adolescents (CBHSQ, 2014).
2.2.1. Past-year frequent NMUPO users
NMUPO was defined as any self-reported use of prescription
pain relievers that were not prescribed for the respondent or that
the respondent took only for the experience or feeling they caused
(National Household Survey on Drug Abuse, 2010a,b, 2012, 2013).
In order to reduce false-positive responses, all respondents were
given the following instructions: “These questions are about pre-
scription pain reliever use. We are not interested in your use of
over-the-counter pain relievers that can be bought in stores
without a doctor’s prescription.” The survey used discrete ques-
tions and a cardwith pictures of many types of prescription opioids.
The respondents were askedwhich ones he/she had used, as well as
frequency of use. Users were classified both by whether they had
ever used opioids non-medically and whether they had used in the
past year. We defined as past-year frequent NMUPO users those
that had used prescription opioids non-medically on at least 120
days in the past-year (n ¼ 806). Because there is no standard
definition for frequent NMUPO use, our definition of frequent users
is similar to the definition existing literature proposed by Jones
(2012) to explore different DSM phenotypes among those with a
high likelihood of developing OUD (i.e., using POs nonmedically at
least twice a week).
The 806 subjects who reported NMUPO at least 120 days in the
past year were asked a series of 17 structured questions derived
from past-year DSM-IV opioid abuse/dependence criteria
embedded in the 2011e2012 NSDUH questionnaire. These ques-
tions were combined to generate 10 dichotomous variables
matching 10 of the 11 DSM-5 criteria. The only DSM-5 OUD crite-
rion that was not included in the 2011e2012 NSDUH questionnaire
was the craving criterion, which is derived from ICD-10 diagnosis of
dependence. The abbreviation of the variable names was based on
previously published studies (Hasin and Beseler, 2009; Shmulewitz
et al., 2010; Castaldelli-Maia et al., 2014a,b): Tolerance, Withdrawal,
Larger/Longer, Quit/Control, Time Spent, Given Up, Physical/Psy-
chological, Major Role, Social/Interpersonal, and Hazardous Use.
2.2.2. Sociodemographic correlates
The following sociodemographic correlates were included in the
regression models based on a previous LCA study (Ghandour et al.,
J.M. Castaldelli-Maia et al. / Journal of Psychiatric Research 80 (2016) 79e86 812008): sex (female and male), age (categorized as 12e17, 18e25,
26e34, and 35 years); education (low: ¼ less than high school;
low-average: ¼ high school graduate; high-average: ¼ some col-
lege; high: ¼ college graduate); race/ethnicity (non-Hispanic (NH)
White, NH Black, Hispanic, and other); marital status (married/
cohabiting, previously married: ¼ separated/divorced/widowed,
never married); and income, defined in categories (poverty, low
income ¼ up to twice the Federal poverty threshold, high
income: ¼ more than twice the Federal poverty threshold,
students:¼ persons aged 18 to 22 living in a College dorm).We also
included three variables that were described as important corre-
lates of NMUPO use in non-LCA studies (Nielsen et al., 2011; Fibbi
et al., 2012; Wang et al., 2013): Metropolitan Statistical Area
(large metropolitan area, small metropolitan area, and non-
metropolitan area); health insurance (yes or no); and employ-
ment status (employed, unemployed, and missing).
2.2.3. Psychiatric comorbidity, NMUPO sources, and other
substance dependence
Three potential psychiatric-related correlates were included in
the regression model: (i) past-year anxiety disorder; (ii) past-year
major depressive episode (MDE); and (iii) antisocial behaviors.
Three variables that indicated sources of NMUPO (how respondents
obtained POs in the past month in the last time they used these
drugs) were included in the regression model: (i) Doctor shopping;
(ii) Bought from a drug dealer, and (iii) Obtained PO from family/
friends. More details on psychiatric comorbidity, NMUPO sources,
and other substance dependence can be found in Supplementary
File 6.
2.2.4. Lifetime treatment for prescription opioid disorders and
mental health/addiction treatment
A respondent was classified as receiving past-year mental
health or addiction treatment if she/he received treatment in any
location formental health disorders, or alcohol or drug problems, in
the past year. Finally, we created a past-year prescription opioid
treatment variable based on the self-report data of receiving
treatment in the last 12 months, including current treatment (or
counseling) for PO use.
2.3. Statistical analysis
All analyses were performed with Mplus version 7, using sam-
plingweights and the complex survey designmeasures. Descriptive
statistics were used to describe the sample. Specifically, counts and
percentages were used to describe categorical variables.
A confirmatory factor analysis (CFA) unidimensional model was
carried out using considering the 10 criteria as categorical variables.
IRT models were used to study the latent opioid use disorder
construct. IRT models analyze the relationship between the prob-
abilities of an individual to endorse a certain response to an item.
IRT analysis implemented in Mplus was used to derive two main
parameters, the threshold and the discrimination parameters. The
first refers to the ‘severity’ of a criterion (threshold), with high
severity items being those that the individual should have worse
OUD (the latent trait) in order to endorse the criterion. The second
parameter measures the ability of a criterion to discriminate re-
spondents from low to high levels of the disorder continuum
(slope).
LCAwas conducted using maximum likelihood ratio estimation.
The random option inMplus was used to ensure convergence of the
most successful LCA models. Specifically, 500 sets of random
starting values were used in the initial phase, and 5 optimizations
were used in the final stage of convergence. This process ensured
that the best log-likelihood value for each model was replicatedseveral times. Several statistical indices were used to assess the fit
of the models, including log-likelihood (LL), Akaike Information
Criterion (AIC), Bayesian Information Criterion (BIC) and sample-
size-adjusted BIC (SSABIC). A low value of log-likelihood together
with smaller amounts in AIC BIC, and SSABIC may reflect a more
parsimonious model (Muthen, 2006). However, the BIC value has
been shown to be more reliable than other information (Nylund
et al., 2007).
Once the number of classes was determined, we used 2 polyt-
omous logistic regression models (pseudo-class draw method) to
investigate the association between latent classes and: (i) NMUPO
sources; (ii) sociodemographic characteristics; and (iv) psychiatric
correlates with adjustment for sociodemographic characteristics.
The Mplus auxiliary option was used to identify the prevalence of
alcohol, tobacco, cannabis, cocaine, stimulant, tranquilizer and pain
relievers dependence, mental health/addiction treatment and
treatment for pain relievers disorders, for which the equality of
means across latent classes were tested using pseudo-class-based
multiple imputations (Asparouhov, 2007). Chi-squared tests were
used to compare the prevalence of these variables among the latent
classes.
3. Results
Table 1A presents the results of CFA and IRT models. The one-
dimensional (one-factor model) obtained high loadings (>0.7) on
all 10 criteria of OUD among past-year frequent NMUPO. In the IRT
models, the criteria with the lowest value on severity were Toler-
ance and Time Spent. Moreover, the criteria with greater severity in
these models were Quit/Control and Hazardous Use. Other criteria
that had greater severity were Neglect Roles and Larger/Longer.
Regarding discrimination, all the criteria had strong values.
Table 1B presents the LCA model fit indices. The best LCA model
was the 4-class model. However, one of the latent classes (“Non-
loss control class”) was too small to investigate correlates of
NMUPO (<8% of the sample), which is an aim of the present study.
The LCA graph for this model is presented in Supplementary File 2.
Based on the LCA index, the second best model was the 3-class
model, which had acceptable latent classes sizes. Latent class
structure did not differ by age: the 3-class model was the best fit
when including the adolescent subsample (Supplementary File 3
and 4).
Table 2 presents the weighted probability of endorsement of
OUD criteria in the best-fit model, and the probability of reporting
OUD criteria and prevalence for each latent class. The “Non-
symptomatic class” included individuals with probability close to
zero for all OUD criteria. The “Tolerance-Time Spent class” included
individuals with low probabilities (<30%) of meeting all diagnostic
criteria, with the exception of a high probability of endorsement of
the Tolerance and Time Spent criteria (above 80%), Withdrawal
(48%) and Physical/Psychological (35%). Individuals in the “high-
moderate symptomatic class” had high (>70%) or moderate (>40%)
probabilities of endorsement all the criteria. The largest class was
the “Non-symptomatic class” (40.7%), followed by the “Tolerance-
Time Spent class” (29.0%) and the “High-moderate symptomatic
class” (30.1%). Approximately half of the individuals who reported
Tolerance and Time Spent criteria were in the “Tolerance-Time
Spent control class”. However, most of the individuals who re-
ported all other criteria were in the “high-moderate symptomatic
class”. Tolerance was the criteria with highest prevalence (59.7%) in
the total sample of frequent NMUPO, followed by Time Spent
(55.6%). Supplementary File 1 presents the weighted probability of
endorsement of OUD criteria in the best-fit model.
Table 3A presents the results of the logistic regression models
examining sociodemographic correlates of the two most
Table 1A
Confirmatory factor analysis (CFA) and item response theory (IRT) findings with DSM-5 opioid use disorder among past-year frequent nonmedical prescription opioid users
(those that used at least 120 days) in the United States, 2011e2012.
n* % CFA IRT
One factor Discrimination (SE) Severity (SE)
Tolerance 513 63.6 0.911 2.25 (0.29) 0.38 (0.05)
Withdrawal 314 39.0 0.743 1.11 (0.09) 0.37 (0.06)
Larger/longer 231 28.7 0.827 1.48 (0.12) 0.67 (0.06)
Quit/control 190 23.6 0.710 1.01 (0.08) 1.01 (0.08)
Time spent 485 60.2 0.918 2.35 (0.30) 0.28 (0.04)
Given up 250 31.0 0.948 3.05 (0.36) 0.52 (0.05)
Physical/psychological 293 36.4 0.882 1.89 (0.16) 0.39 (0.05)
Neglect roles 203 25.2 0.934 2.66 (0.31) 0.71 (0.05)
Social/interpersonal 253 31.4 0.887 1.94 (0.16) 0.54 (0.05)
Hazardous 189 23.4 0.808 1.38 (0.11) 0.89 (0.06)
* Estimated value of n since after de imputation of weights/clusters/strata it is not possible to calculate the exact value of n.
** DSM-5 Opioid Use Disorder criteria: Tolerance - as defined by either of the following: (a) a need for markedly increased amounts of opioids to achieve Intoxication or desired
effect; (b) markedly diminished effect with continued use of the same amount of opioid; Withdrawal - as manifested by either of the following: (a) the characteristic
withdrawal syndrome for opioid (refer to Criteria A and B of the criteria sets for withdrawal from alcohol); (b) opioids (or a closely related substance) is used to relieve or avoid
withdrawal criteria; Larger/Longer - opioids is often used in larger amounts or over a longer period than was intended; Quit/Control - there is a persistent desire or un-
successful efforts to cut down or control opioid use; Time Spent - a great deal of time is spent in activities necessary to obtain opioid, use opioid, or recover from its effects;
Given Up - important social, occupational, or recreational activities are given up or reduced because of opioid use; Physical/Psychological - alcohol use is continued despite
knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by opioid; Neglect Roles - recurrent opioid
use resulting in a failure to fulfill major role obligations at work, school, or home; Social/Interpersonal - continued opioid use despite having persistent or recurrent social or
interpersonal problems caused or exacerbated by the effects of the opioid; Hazardous Use - recurrent opioid use in situations in which it is physically hazardous. Craving
criterion was not included in the present study.
Table 1B
LCA model fit statistics of 10 of the 11 DSM-5 opioid use disorder criteria among those that used prescripton opioids at least 120 days in the past year.
Model LL AIC BIC SSABIC p-Vuong Entropy df Low class %
Two-class 3420.307 6930.614 7141.758 6998.857 0.046 0.931 1001 43.5
Three-class 3103.551 6367.102 6742.469 6488.423 0.715 0.921 990 29.0
Four-class 2956.643 6143.286 6682.875 6317.684 0.799 0.943 975 7.4
Five-class 2878.842 6057.684 6761.497 6285.161 0.760 0.953 965 7.3
Six-class 2760.087 5890.174 6758.209 6170.728 0.761 0.966 954 8.4
Seven-class 2734.234 5908.469 6940.727 6242.100 0.755 0.967 943 3.2
Eight-class 2693.464 5896.928 7093.410 6283.638 0.760 0.976 935 1.8
LL ¼ Log-likelihood; AIC ¼ Akaike Information Criteria; BIC ¼ Bayesian Information Criteria; SSABIC ¼ Sample-size adjusted BIC; p-Vuong ¼ p of Vuong-Lo-Mendel-Rubin;
df ¼ degrees of freedom; NC ¼ The model did not reach convergence.
Table 2
Conditional prevalence per three latent classes of DSM-5 opioid use disorder among past-year frequent nonmedical prescription opioid users (those that used at least 120 days)
in the United States, 2011e2012.
Criteria “Non-symptomatic class” “Tolerance-time spent class” “High-moderate symptomatic
class”
Total
n* % SE n* % SE n* % SE n* %
Tolerance 59 13.8 0.02 301 89.0 0.02 242 97.0 0.01 601 59.4
Withdrawal 22 5.3 0.01 147 43.6 0.03 187 74.9 0.03 356 35.2
Larger/longer 5 1.1 0.01 94 27.9 0.03 154 61.8 0.03 253 25.0
Quit/control 11 2.6 0.01 66 19.4 0.03 125 50.3 0.03 202 20.0
Time spent 33 7.9 0.02 298 88.1 0.02 238 95.5 0.02 569 56.3
Activities given up 4 0.9 0.01 51 15.1 0.03 238 95.4 0.02 292 28.9
Physical/psychological 4 0.9 0.01 108 32.1 0.03 220 88.3 0.02 332 32.9
Neglect roles 10 2.3 0.01 22 6.6 0.02 211 84.7 0.03 243 24.0
Social/interpersonal 3 0.8 0.01 72 21.2 0.03 216 86.7 0.02 291 28.8
Hazardous use 0 0.0 0.00 62 18.3 0.02 165 66.4 0.03 227 22.5
Total 424 41.93 0.00 338 33.43 0.00 249 24.62 0.00 1011 100.00
* Estimated value of n since after de imputation of weights/clusters/strata it is not possible to calculate the exact value of n.
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ence. Those in the “Tolerance-Time Spent class” were more likely
than those in class the “Non-symptomatic class” to be younger
(18e25 years) and Non-Hispanic White (vs. ‘Other’ racial/ethnic
groups) while those in the “High-Moderate symptomatic class”
were more likely than those in the “Non-symptomatic class” to be
male, Non-Hispanic White (vs. ‘Other’ racial/ethnic groups) and to
have insurance.Table 3B presents the results of the logistic regression models
examining psychiatric and sources correlates, with adjustment for
all sociodemographics included in Table 3A. The two symptomatic
classes (as compared to class the “Non-symptomatic class”) were
significantly associated with antisocial behaviors and buying POs
from drug dealers in the past month as compared to the non-
symptomatic class. Those in the “Tolerance-Time Spent class”
were more likely than those in the “Non-symptomatic class” to
Table 3A




“Non-symptomatic” “High-moderate symptomatic class”
n* % n* % aOR 95%CI p n* % aOR 95%CI p
Gender
Female 185 43.6 112 33.0 1.00 72 28.8 1.00
Male 239 56.4 226 67.0 1.64 0.89e3.00 0.107 177 71.2 1.51 1.25e3.98 0.006
Income
Medium income 121 28.6 93 27.6 1.00 65 26.3 1.00
Poverty 114 26.8 81 23.9 1.37 0.50e3.71 0.532 61 24.5 1.09 0.45e2.64 0.835
High income 189 44.6 164 48.5 1.18 0.43e3.24 0.739 123 49.2 1.63 0.74e3.57 0.221
Metropolitan area
Large 224 52.8 150 44.3 1.00 127 50,7 1.00
Small 127 30.0 115 34.1 1.08 0.55e2.13 0.810 82 33.1 0.93 0.43e1.96 0.849
Non-metropolitan area 73 17.2 73 21.6 1.45 0.63e3.35 0.375 40 16.2 0.99 0.38e2.59 0.992
Insurance
No 146 34.4 139 41.2 1.00 92 37.1 1.00
Yes 278 65.6 199 58.8 1.10 0.62e1.94 0.732 157 62.9 2.08 1.11e3.87 0.021
Employment status
Employed 259 61.0 222 65.7 1.00 138 55.3 1.00
Unemployment 165 39.0 116 34.3 0.70 0.39e1.26 0.242 111 44.7 1.51 0.79e2.89 0.210
Race
Non-hispanic white 270 63.6 274 81.2 1.00 216 86.7 1.00
Non-hispanic black 60 14.2 21 6.2 0.63 0.20e1.90 0.413 7 2.9 0.28 0.05e1.35 0.114
Hispanic 67 15.9 30 8.8 0.63 0.26e1.48 0.294 19 7.6 0.41 0.17e0.96 0.040
Other 27 6.3 13 3.8 0.29 0.15e0.58 <0.001 7 2.8 0.30 0.09e0.92 0.037
Education (in years)
Low 107 25.3 74 21.7 1.00 67 26.8 1.00
Low-average 156 36.8 130 38.6 1.45 0.57e3.68 0.424 82 32.8 0.67 0.28e1.60 0.367
High-average 124 29.2 94 27.8 1.26 0.53e3.02 0.596 81 32.7 0.92 0.38e2.20 0.861
High 37 8.7 40 11.9 2.65 0.79e8.90 0.114 19 7.7 0.87 0.16e4.62 0.872
Marital status
Never married 212 50.1 185 54.6 1.00 156 62.9 1.00
Widow/separated/divorced 70 16.4 70 20.8 2.50 0.84e7.41 0.096 51 20.3 2.15 0.85e5.38 0.102
Married/cohabiting 142 33.5 83 24.6 1.24 0.47e3.26 0.660 42 16.8 0.59 0.21e1.60 0.302
Age (in years)
18e25 19 4.4 31 9.1 1.00 19 7.4 1.00
26e34 275 64.8 210 62.2 0.66 0.45e0.99 0.046 157 63.2 0.95 0.58e1.55 0.851
35 or more 131 30.8 97 28.7 0.18 0.07e0.48 0.001 73 29.4 0.46 0.17e1.24 0.221
Survey year
2011 216 50.9 176 52.1 1.00 133 53.4 1.00
2012 208 49.1 162 47.9 1.08 0.55e2.10 0.809 116 46.6 1.09 0.60e1.98 0.763
Bold: significant associations (p < 0.05).
* Estimated value of n since after de imputation of weights/clusters/strata it is not possible to calculate the exact value of n.
** Non-symptomatic class was the reference category for other latent classes.
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Moderate symptomatic class” were more likely than those in the
“Non-symptomatic class” to have obtained POs via Doctor
shopping.
Table 4 presents progressively higher values (“High-moderate
symptomatic class” > “Tolerance-Time Spent class” > “Non-symp-
tomatic class”) of conditional prevalence of past-year other sub-
stance dependence, and previous or current treatment for PO
disorders and Mental Health/Addiction, in each of the 3 latent
classes. Despite a high past-year prevalence of opioid dependence
among those on the “Tolerance-Time Spent class” and the “High-
moderate symptomatic class” (63.1% and 98.6%, respectively), a
very low proportion of respondents in “Tolerance-Time Spent class”
sought treatment for opioid disorders secondary to NMUPO (8.2%),
in contrast with those in “high-moderate class”, in which 36.4%
sought treatment for opioid disorders secondary to NMUPO. The
highest prevalence of comorbidity was found for tobacco depen-
dence, followed by alcohol dependence (70.4% and 29.4%, respec-
tively, in the “high-moderate symptomatic class” and 60.6%, 15.9%,
respectively, in the “Tolerance-Time Spent class”, respectively).
Cocaine dependence (15.5%) reached a higher value than cannabis
dependence (14.4%) in “High-moderate symptomatic class” whichwas not the case of “Tolerance-Time Spent class” (5.9% and 10.6%,
respectively). Supplementary File 5 presents the weighted counts
and proportions, and the standard errors for each variable included
in the logistic regression models and for latent class conditional
prevalence.4. Discussion
The CFA and LCA of an epidemiological household sample of US
frequent nonmedical prescription opioid users yielded support for
an unidimensional model of OUD criteria and for a three-class
model (LCA) as the overall best solution for dividing frequent
users in phenotypes along this unidimensional continuum. The
three-class model identified a “Non-symptomatic” class, an inter-
mediate class with high probability of endorsing Tolerance and
Time Spent symptoms, and a high-moderate symptom class. There
was also an increasing prevalence of past-month tobacco depen-
dence, and past-year alcohol dependence from the “Non-symp-
tomatic class” to the “Tolerance-Time spent class” to the “High-
moderate symptomatic class”. Interestingly, those in the “Toler-
ance-Time Spent class” were more likely to obtain PO from family/
friends while those in the “High-moderate symptomatic class” (vs.
Table 3B
Logisitic regression models results of psychiatric and sources correlates within latent classes DSM-5 opioid use disorder among those that used prescripton opioids at least 120
days in the past year.
Variable “Non-
symptomatic”
“Tolerance-time spent class” “High-moderate
symptomatic class”
n* % n* % aOR 95%CI p n* % aOR 95%CI p
Anxiety disorders 56 13.1 66 19.4 1.31 0.58e2.98 0.506 66 26.7 1.88 0.82e4.29 0.132
Major depressive
disorder
56 13.1 62 18.4 1.44 0.68e3.03 0.330 65 26.0 1.61 0.65e3.98 0.302
Antisocial behaviors 51 12.0 118 34.8 3.33 1.75e6.35 <0.001 150 60.2 9.43 4.53e19.66 <0.001
Doctor shopping 81 19.0 80 23.7 1.74 0.80e3.79 0.162 74 29.6 2.60 1.29e5.24 0.008
Bought from a drug
dealer
28 6.7 94 27.7 4.81 1.79e12.88 0.002 78 31.3 6.58 2.89e14.98 <0.001
Obtained PO from
family/friends
137 32.4 199 58.8 2.97 1.54e5.72 0.001 121 48.4 1.52 0.82e2.78 0.176
Bold: significant associations (p < 0.05).
* Estimated value of n since after de imputation of weights/clusters/strata it is not possible to calculate the exact value of n.
** Non-symptomatic class was the reference category for other latent classes.
PO ¼ prescription opioids.
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doctor shoppers.
Only two studies evaluated the dimensionality of OUD (Wu
et al., 2009, 2011) by EFA and both examined the dimensionality
of criteria among those any past-year NMUPO. Our study shares
some similarities with these studies but focuses on a sample that
included only frequent users. Frequent users are a group that is
most likely to generate data that could inform prevention and
treatment because these individuals are at considerable risk for
having OUD. Both studies gave support to an unidimensional model
(Wu et al., 2009, 2011), which allowed us to run a CFA in our more
restricted sample of frequent users. Our study did not include the
Legal Problems criterion because of its exclusion in DSM-5
(American Psychiatric Association, 2013), gives support to a uni-
dimensional model for OUD, despite not including the Craving
criterion. An important future direction is to assess LCA in data
sources with complete DSM-5 criteria as it was carried out for the
entire class of opioids (Tarrahi et al., 2015).
Our IRT model findings are presented in a similar way to the
findings of previous studies with U.S. adolescent (Wu et al., 2009)
and adult (Wu et al., 2011) samples of any nonmedical users. Larger/
Longer and Quit/Control were found to be the criteria that endorsed
by those individuals who probably endorsed several other OUD
criteria. In contrast, Tolerance and Time Spent seem to be the first
OUD criteria endorsed from the 10 criteria tested (Wu et al., 2009,
2011). Interestingly, Hazardous Use was more severe among in-
dividuals in our study than in Wu et al.’ study (2011). Wu et al.
(2011) divided their sample into most affected and less affected
groups by factor mixture model. We compared our IRT results with
the most affected group since we focused our analyses on frequentTable 4
Conditional prevalence per three latent classes of DSM-5 opioid use disorder among tho
Latent class “Non-symptomatic class” “To
% (SE) % (S
Treatment for DSM-IV pain relivers (opioid) disorders 1.1 (0.01) 8.2
Treatment for mental health/addiction 25.2 (0.02) 36.7
DSM-IV alcohol dependence 15.2 (0.02) 15.9
Tobacco dependence (FTND or NDSS) 48.6 (0.02) 60.6
DSM-IV cannabis dependence 4.3 (0.01) 10.6
DSM-IV cocaine dependence 5.5 (0.01) 5.9
DSM-IV stimulant dependence 0.6 (0.01) 3.9
DSM-IV tranquilizers dependence 0.0 (0.01) 3.5
DSM-IV pain relivers (opioid) dependence 0.0 (0.01) 63.1
SE ¼ Linearized Standard Error.users.
To date, only a few studies have used LCA to understand
phenotypic differences of opioid dependence symptoms among
nonmedical prescription opioid users and none of them focused on
frequent users (Ghandour et al., 2008; Wu et al., 2011). Similarly to
these studies (Ghandour et al., 2008;Wu et al., 2011), we also find a
large non-symptomatic class and a class with a high probability of
satisfying the criteria “Tolerance” and “Time Spent” with a mod-
erate probability of endorsement of the other criteria. In addition,
we also found a “high-moderate symptomatic class” as Ghandour
et al.’s study (2008). The only class found by Ghandour et al.
(2008) and not found in the present study was one latent class
related to adolescents. This could be explained by the fact that we
did not include adolescents in our analyses. Despite similarities
regarding the latent classes found in Ghandour et al.’ study and the
present study, the sociodemographic correlates were quite
different, maybe because we focused on frequent NMUPO users
while the Ghandour study focused on any past-year NMUPO. For
example, they reported that being female was significantly asso-
ciated with the symptomatic classes, which differs from our finding
of association of males having a higher likelihood of being in the
most symptomatic class compared to females. Differences could be
explained by the differences between the selected samples (any
NMUPO and frequent NMUPO, respectively). We analyzed data
from a sample of adults only, withmore frequent use, andwith data
collected about a decade later. Unfortunately, Wu et al. (2011) did
not analyze sociodemographic correlates of the latent classes.
Both symptomatic classes did not differ regarding the psychi-
atric correlates - both were more strongly associated with antiso-
cial behaviors as compared to the “Non-symptomatic class”.se that used prescripton opioids at least 120 days in the past year.
lerance-time spent class” “High-moderate symptomatic class” Chi-squared test
E) % (SE) p
(0.01) 36.4 (0.03) <0.001
(0.03) 58.0 (0.03) <0.001
(0.02) 29.4 (0.03) <0.001
(0.03) 70.4 (0.03) <0.001
(0.02) 14.4 (0.02) <0.001
(0.01) 15.5 (0.02) 0.001
(0.01) 11.7 (0.02) <0.001
(0.01) 12.5 (0.02) <0.001
(0.03) 98.6 (0.01) <0.001
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difference. Despite both symptomatic classes (as compared to the
“Non-symptomatic class”) being more strongly associated with
buying from a drug dealer, the “Time Spent-Tolerance class” was
significantly associated with obtaining PO from family/friends,
while the “High-Moderate symptomatic class” was significantly
associated with “doctor shopping”. Most importantly, these dif-
ferences persisted after adjustment for sociodemographic charac-
teristics, including gender, which has been associated with these
types of sources - i.e., female gender is more strongly associated
with doctor-shopping (Back et al., 2010). It is important to target
respondents from both classes to seek treatment, since despite the
prevalence of DSM-IV Opioid Dependence in those classes being
high, treatment prevalence is very low in both.
More than 60% of the individuals in the “high-moderate
symptomatic class” did not seek for treatment for OUD. Considering
the high prevalence of comorbid conditions, including multiple
substance use disorders and a higher lifetime prevalence of mental
health/addiction treatment (58%), it is possible that would be easier
to find these individuals, who were predominantly Non-Hispanic
White males with health insurance, in psychiatric and substance
abuse treatment settings if they seek treatment for comorbid
conditions. However, there must be a contingent of individuals in
this class who do not seek treatment both for OUD and comorbid
conditions.
Due to the cross-sectional design of the NSDUH survey, the as-
sociations reported here, even if statistically significant, reflect
correlations and should not be viewed as providing evidence sup-
porting etiological pathways. Although the NSDUH is an annually
administered national survey, it does not capture the same in-
dividuals every year. A second limitation is the use of self-report.
However, the use of a computerized reporting system, ACASI,
minimizes social desirability biases, and yields data likely to be
internally consistent and complete (Turner et al., 1998). We have
also not included the Craving criterion in the present analyses since
the NSDUH data does not include it, despite some recent studies
that state the importance of this symptom for different samples of
prescription opioid users (Ashrafioun and Carels, 2014; Wasan
et al., 2012). In addition, the definition of doctor shopping used
was broad, and has the potential to bemisleading for policymakers.
Unfortunately, the NSDUH does not have a more restrictive/refined
definition of doctor shopping. We also could not distinguish
whether these NMUPO users first started using these drugs when
legitimately prescribed (e.g., pain relief) or when obtained illegally
(i.e., to get high); such data were unavailable in the NSDUH.
Gathering such data in future studies will help us better understand
the profiles of these users, which may be distinct. Finally, the an-
alytic focus of this manuscript was specifically on frequent NMUPO
users. Thus, it was not possible to generalize it to people that less
frequently engage NMUPO.
In summary, this study showed that frequent NMUPO users
exhibit three different types of OUD phenotypes. Both the Toler-
ance and Time Spent criteria (which are included in DSM-5 OUD)
seem important to identify phenotypes of frequent prescription
opioid users in this and in previous studies. There is an interme-
diate class of Non-Hispanic White young adults who get PO from
family and friends, with high probability of endorsing tolerance and
spend a lot of time searching for, using or recovering from PO.
Finally, the most symptomatic class consisting of White Non-
Hispanic males with health insurance, and that is significantly
associated doctor shopping. Both classes call attention because of
their low level of treatment seeking. It is possible that these groups
may respond to different interventions, however such conclusions
would require a clinical study. The present study did not find very
different phenotypes of individuals among frequent nonmedicalprescription opioid users (i.e., physical versus psychological), but
the phenotypes found in this study are within the OUD continuum,
which could corroborate with the findings of the several studies
evaluating the dimensionality of the DSM-5 Substance Use Disor-
der (Shmulewitz et al., 2015). However, it is undeniable that both
symptomatic classes described in this study have very different
socio-demographic correlates, and present an important differen-
tiation in regards to prescription opioids sources (doctor shopping
versus family). Therefore, our study presents important public
health implications to distinguish subgroups of frequent nonmed-
ical prescription opioid users. Furthermore, this study may be of
particular interest for future phenotypic investigations in different
populations in the U.S. and in other countries.
Financial support
 Dr. Castaldelli-Maia receives Pfizer Independent Grant for
Learning and Change (IGLC) managed by Global Bridges
(Healthcare Alliance for Tobacco Dependence Treatment) hosted
at Mayo Clinic, to support free smoking cessation treatment
training in addiction/mental health care units in Brazil (grant
IGLC 13513957) which had no relationship with the present
study.
 Dr. Martins is currently supported by NIH-NICHD
R01HD060072, NIH-NIDA R01DA037866 and NIH-NIDA
1R01DA039962.
 Dr. Keyes is currently supported by NIH-NIAAA K01AA021511.
 Dr. Cerda is currently supported by NIH-NIDA K01DA030449-01
and NIH-NIDA 1R01DA039962.Contributors
Authors JMC-M, LHA and SSM designed the study. Authors JMC-
M, LHA, KMK, MC, DJP and SSM managed the literature searches
and summaries of previous related work. JMC-M and SSM under-
took the statistical analysis. Author JMC-M and SSM wrote the first
draft of the manuscript. All authors contributed to and have
approved the final manuscript.
Conflict of interest
Dr. Martins worked in 2014 as a consultant to Purdue Pharma on
secondary data analyses of nonmedical prescription opioid and
alcohol use in a different dataset, unrelated to the data described in
this manuscript.
Acknowledgements
 Substance Abuse and Mental Health Data Archive (SAMHDA),
sponsored by U.S. Department of Health and Human Services.
 Inter-university Consortium for Political and Social Research
(ICPSR), U.S.
 SAMHSA and ICPSR have no responsibility for the use of the
data or for the interpretations and inferences made in the present
study.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jpsychires.2016.05.007.
References
American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental
J.M. Castaldelli-Maia et al. / Journal of Psychiatric Research 80 (2016) 79e8686Disorders, fifth ed. American Psychiatric Association, Arlington.
Ashrafioun, L., Carels, R.A., 2014. Prescription opioid use among university students:
assessment of post-cue exposure craving. Addict. Behav. 39, 586e592.
Asparouhov, T., 2007. Wald Test of Mean Equality for Potential Latent Class Pre-
dictors in Mixture Modeling. http://www.statmodel.com/download/MeanTest1.
pdf (accessed in 13.12.13.).
Back, S.E., Payne, R.L., Simpson, A.N., Brady, K.T., 2010. Gender and prescription
opioids: findings from the national survey on drug use and health. Addict.
Behav. 35, 1001e1007.
Boscarino, J.A., Rukstalis, M.R., Hoffman, S.N., Han, J.J., Erlich, P.M., Ross, S.,
Gerhard, G.S., Stewart, W.F., 2011. Prevalence of prescription opioid-use disorder
among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic
criteria. J. Addict. Dis. 30, 185e194.
Castaldelli-Maia, J.M., Martins, S.S., de Oliveira, L.G., van Laar, M., de Andrade, A.G.,
Nicastri, S., 2014a. Use transition between illegal drugs among Brazilian uni-
versity students. Soc. Psychiatry Psychiatr. Epidemiol. 49, 385e394.
Castaldelli-Maia, J.M., Silveira, C.M., Siu, E.R., Wang, Y.P., Milhorança, I.A., Alexan-
drino-Silva, C., Borges, G., Viana, M.C., Andrade, A.G., Andrade, L.H., Martins, S.S.,
2014b. DSM-5 latent classes of alcohol users in a population-based sample:
results from the S~ao Paulo megacity mental health survey, Brazil. Drug Alcohol
Depend. 136, 92e99.
Center for Behavioral Health Statistics and Quality, 2014. National Survey on Drug
Use and Health (NSDUH): Summary of Methodological Studies, 1971e2014.
Substance Abuse and Mental Health Services Administration. MD, Rockville.
Centers for Disease Control and Prevention (CDC), 2011. Vital signs: overdoses of
prescription opioid pain relievers-United States, 1999e2008. Morb. Mortal.
Wkly. Rep. 60, 1487e1492.
Centers for Disease Control and Prevention (CDC), 2015. Increases in drug and
opioid overdose deaths-United States, 2000e2014. Morb. Mortal. Wkly. Rep. 64,
1378e1382.
Daniulaityte, R., Falck, R., Carlson, R.G., 2014. Sources of pharmaceutical opioids for
non-medical use among young adults. J. Psychoact. Drugs 46, 198e207.
Fibbi, M., Silva, K., Johnson, K., Langer, D., Lankenau, S.E., 2012. Denial of prescrip-
tion opioids among young adults with histories of opioid misuse. Pain Med. 13,
1040e1048.
Ghandour, L.A., Martins, S.S., Chilcoat, H.D., 2008. Understanding the patterns and
distribution of opioid analgesic dependence symptoms using a latent empirical
approach. Int. J. Methods Psychiatr. Res. 17, 89e103.
Hasin, D.S., Beseler, C.L., 2009. Dimensionality of lifetime alcohol abuse, depen-
dence and binge drinking. Drug Alcohol Depend. 101, 53e61.
Jones, C.M., 2012. Frequency of prescription pain reliever nonmedical use:
2002e2003 and 2009e2010. Arch. Intern. Med. 172, 1265e1267.
Jordan, B.K., Karg, R.S., Batts, K.R., Epstein, J.F., Wiesen, C., 2008. A clinical validation
of the national survey on drug use and health assessment of substance use
disorders. Addict. Behav. 33, 782e798.
Kendler, K.S., Ohlsson, H., Sundquist, K., Sundquist, J., 2013. A latent class analysis of
drug abuse in a national Swedish sample. Psychol. Med. 43, 2169e2178.
Lineberry, T.W., Bostwick, J.M., 2004. Taking the physician out of “physician shop-
ping”: a case series of clinical problems associated with Internet purchases of
medication. Mayo Clin. Proced. 79, 1031e1034.
Muthen, B.O., 2006. Should substance use disorders be considered as categorical or
dimensional? Addiction 101, S6eS16.
National Household Survey on Drug Abuse, 2010a. 2009 public Use File and
Codebook - Substance Abuse and Mental Health Services Administration. Office
of Applied Studies, Rockville.
National Household Survey on Drug Abuse, 2012. 2011 public Use File and Code-
book - Substance Abuse and Mental Health Services Administration. Office of
Applied Studies, Rockville.
National Household Survey on Drug Abuse, 2013. 2012 public Use File and Code-
book - Substance Abuse and Mental Health Services Administration. Office of
Applied Studies, Rockville.National Survey On Drug Use And Health, 2010b. In: S. A. A. M. H. S (Ed.), National
Survey on Drug Use and Health: Overview and Summary of Substate Region
Estimation Methodology, 2008e2010-Administration. http://www.samhsa.gov/
data/NSDUH/substate2k10/Methodology/NSDUHsubstateMethodology2010.pdf
(accessed in 13.10.13.).
Nielsen, S., Cameron, J., Lee, N., 2011. Characteristics of a nontreatment-seeking
sample of over-the-counter codeine users: implications for intervention and
prevention. J. Opioid Manag. 7, 363e370.
Nordmann, S., Pradel, V., Lapeyre-Mestre, M., Frauger, E., Pauly, V., Thirion, X.,
Mallaret, M., Jouanjus, E., Micallef, J., 2013. Doctor shopping reveals
geographical variations in opioid abuse. Pain Physician 16 (1), 89e100.
Nylund, K.L., Asparouhov, T., Muthen, B.O., 2007. Deciding on the number of classes
in latent class analysis and growth mixture modeling: a Monte Carlo simulation
study. Struct. Equ. Model. 14, 535e569.
Paulozzi, L.J., Jones, C., Mack, K., Rudd, R., 2011. Centers for disease control and
prevention (CDC). Vital signs: overdoses of prescription opioid pain relie-
versdUnited States, 1999e2008. Morb. Mortal. Wkly. Rep. 60, 1487e1492.
Pradel, V., Thirion, X., Ronfle, E., Masut, A., Micallef, J., Begaud, B., 2004. Assessment
of doctor-shopping for high dosage buprenorphine maintenance treatment in a
French region: development of a new method for prescription database.
Pharmacoepidemiol. Drug Saf. 13, 473e481.
Saha, T.D., Compton, W.M., Chou, S.P., Smith, S., Ruan, W.J., Huang, B., Pickering, R.P.,
Grant, B.F., 2012. Analyses related to the development of DSM-5 criteria for
substance use related disorders: 1. Toward amphetamine, cocaine and pre-
scription drug use disorder continua using item response theory. Drug Alcohol
Depend. 122, 38e46.
Shmulewitz, D., Greene, E.R., Hasin, D., 2015. Commonalities and differences across
substance use disorders: phenomenological and epidemiological aspects.
Alcohol. Clin. Exp. Res. 39 (10), 1878e1900.
Shmulewitz, D., Keyes, K., Beseler, C., Aharonovich, E., Aivadyan, C., Spivak, B.,
Hasin, D., 2010. The dimensionality of alcohol use disorders: results from Israel.
Drug Alcohol Depend. 111, 146e154.
Substance Abuse and Mental Health Services Administration, 2012. Results from the
2011 National Survey on Drug Use and Health: Summary of National Findings.
Substance Abuse and Mental Health Services Administration, Rockville, MD,
2012. NSDUH Series H-44, HHS Publication No (SMA): 12e4713.
Substance Abuse and Mental Health Services Administration, 2013. Results from the
2012 National Survey on Drug Use and Health: Summary of National Findings.
Substance Abuse and Mental Health Services Administration, Rockville, MD,
2013. NSDUH Series H-46, HHS Publication No. (SMA) 13e4795.
Tarrahi, M.J., Rahimi-Movaghar, A., Zeraati, H., Motevalian, S.A., Amin-Esmaeili, M.,
Hajebi, A., Sharifi, V., Radgoodarzi, R., Hefazi, M., Fotouhi, A., 2015. Latent class
analysis of DSM-5 criteria for opioid use disorders: results from the Iranian
National Survey on mental health. Eur. Addict. Res. 21, 144e152.
Turner, C.F., Ku, L., Rogers, S.M., Lindberg, L.D., Pleck, J.H., Sonestein, F.L., 1998.
Adolescent sexual behavior, drug use, and violence: increased reporting with
computer survey technology. Science 280, 867e873.
Wang, K.H., Becker, W.C., Fiellin, D.A., 2013. Prevalence and correlates for
nonmedical use of prescription opioids among urban and rural residents. Drug
Alcohol Depend. 127, 156e162.
Wasan, A.D., Ross, E.L., Michna, E., Chibnik, L., Greenfield, S.F., Weiss, R.D.,
Jamison, R.N., 2012. Craving of prescription opioids in patients with chronic
pain: a longitudinal outcomes trial. J. Pain 13, 146e154.
Wu, L.T., Ringwalt, C.L., Yang, C., Reeve, B.B., Pan, J.J., Blazer, D.G., 2009. Construct
and differential item functioning in the assessment of prescription opioid use
disorders among American adolescents. J. Am. Acad. Child Adolesc. Psychiatry
48, 563e572.
Wu, L.T., Woody, G.E., Yang, C., Pan, J.J., Blazer, D.G., 2011. Abuse and dependence on
prescription opioids in adults: a mixture categorical and dimensional approach
to diagnostic classification. Psychol. Med. 41, 653e664.
